Equine Headshaking Syndrome: Diagnostic Workup and Management

Equine headshaking syndrome presents as involuntary, repetitive head flicking, jerking, or shaking that can interfere with riding, handling, and quality of life. This article provides a systematic diagnostic approach to rule out other causes of headshaking and reviews current medical and surgical management options. The goal is to help veterinarians move from clinical presentation to a practical, evidence-informed diagnostic and treatment plan.

At a Glance: Equine Headshaking Syndrome

Defining Equine Headshaking Syndrome

Equine headshaking syndrome is a clinical condition characterized by involuntary, repetitive, and often violent shaking, flicking, or jerking of the head. It is a diagnosis of exclusion, meaning other causes of head pain or irritation must be ruled out first. The condition is most commonly associated with hypersensitivity of the trigeminal nerve, specifically the infraorbital branch, leading to a sensation similar to a phantom itch or electric shock in the horse's face.

A study on the prevalence of headshaking within the equine population in the UK found that the condition affects a notable number of horses, with many owners reporting a seasonal pattern (Equine veterinary journal, 2018). The condition can be debilitating, affecting the horse's ability to eat, be ridden, and interact normally. An early survey on equine headshaking documented that affected horses may show behavioral changes and reduced performance (The Veterinary record, 1997).

Clinical Presentation and Initial Assessment

The first step is a thorough history and physical examination. You must distinguish idiopathic headshaking from headshaking caused by a treatable primary problem.

History Taking

Ask the owner specific questions to characterize the behavior and identify potential triggers:

• When did the behavior start? Is it seasonal?
• Is the headshaking present at rest, during exercise, or both?
• Does it occur in specific environments such as in sunlight, in the stable, or during windy weather?
• Is there any nasal discharge, sneezing, or coughing?
• Has the horse had any recent trauma, dental work, or eye problems?
• What is the horse's response to a fly mask or nose net?
• Are there any other horses on the property with similar signs?
• Does the horse show any other behavioral changes such as reluctance to be bridled or head shyness?

Physical and Neurologic Examination

Perform a complete physical examination, paying close attention to the head and neck.

Ophthalmic Examination: A thorough eye exam is essential. Conditions like uveitis, corneal ulcers, or cataracts can cause photophobia and secondary headshaking. Use a slit lamp and fluorescein stain if indicated. Examine both eyes carefully, as subtle lesions can be missed without magnification.

Oral and Dental Examination: A full oral exam with a speculum is mandatory. Look for sharp enamel points, loose or fractured teeth, periodontal disease, or oral ulcers. Dental pain is a common cause of head tossing that can mimic headshaking syndrome. Palpate the temporomandibular joint for pain or crepitus.

Neurologic Examination: Assess cranial nerve function, especially the trigeminal nerve (facial sensation, jaw tone). Look for other signs of neurologic disease such as ataxia, weakness, or head tilt. A basic neurologic exam can help rule out conditions like equine protozoal myeloencephalitis or cervical vertebral stenotic myelopathy.

Ear Examination: Otoscopic examination of the external ear canal and tympanic membrane is important. Look for foreign bodies, parasites, or infection. Ear mites or fungal infections can cause intense irritation leading to head shaking.

Palpation of the Head and Neck: Palpate the parotid salivary gland, guttural pouches, and cervical muscles for pain or swelling. Check for pain on poll flexion or neck extension.

Urgent Veterinary Escalation Criteria

If the horse shows any of the following, immediate referral to a veterinary hospital is warranted:

• Acute onset of severe, uncontrollable headshaking that prevents the horse from eating or drinking
• Signs of neurologic disease such as ataxia, weakness, seizures, or altered mentation
• Evidence of severe ocular pain including blepharospasm, corneal edema, or hypopyon
• Suspected fracture or trauma to the skull
• Progressive worsening of signs over days instead of weeks or months

Diagnostic Workup: Ruling Out Other Causes

The diagnostic workup for headshaking is a systematic process of elimination. The goal is to identify or rule out every other potential cause of head pain or irritation before labeling the condition as idiopathic or trigeminal-mediated.

Step 1: Basic Diagnostics

Complete Blood Count and Serum Biochemistry: These are often normal in idiopathic headshaking but can help identify systemic illness or inflammation. Look for elevated inflammatory markers that might suggest an infectious or immune-mediated process.

Endoscopic Examination of the Upper Airway: Perform a standing endoscopic exam of the nasal passages, pharynx, larynx, and guttural pouches. Look for signs of infection, inflammation, masses, or foreign bodies. A study on idiopathic headshaking questioned whether the condition is truly idiopathic, suggesting that some cases may have an underlying infectious or inflammatory component (Veterinary journal, 2014). Examine the guttural pouches carefully for chondroids or empyema.

Radiography of the Skull and Cervical Spine: Skull radiographs can help identify dental disease, sinusitis, or fractures. Cervical spine radiographs are indicated if there is any suspicion of neck pain or neurologic disease. Obtain multiple views including lateral and oblique projections of the skull.

Step 2: Advanced Diagnostics

If basic diagnostics are negative, consider advanced imaging and specialized tests.

Computed Tomography (CT) of the Skull: CT provides excellent detail of the dental structures, sinuses, and temporomandibular joint. It is superior to radiography for identifying subtle dental disease, sinus cysts, or bone lesions. CT is particularly useful for evaluating the apical regions of cheek teeth and the temporomandibular joint.

Magnetic Resonance Imaging (MRI) of the Brain and Trigeminal Nerve: MRI is the gold standard for evaluating the brain and cranial nerves. While a study found that trigeminal nerve root demyelination was not seen in six horses diagnosed with trigeminal-mediated headshaking (Frontiers in Veterinary Science, 2017), MRI can still rule out other intracranial pathology such as neoplasia, abscess, or inflammatory lesions.

Cerebrospinal Fluid (CSF) Analysis: CSF analysis can help diagnose inflammatory or infectious conditions of the central nervous system, such as equine herpesvirus myeloencephalopathy or protozoal infection. A study investigated the link between latent equine herpesvirus-1 in trigeminal ganglia and equine idiopathic headshaking, suggesting a possible viral trigger in some cases (Journal of veterinary internal medicine, 2012). Collect CSF from the atlanto-occipital or lumbosacral site depending on the suspected lesion location.

Allergy Testing: Intradermal skin testing or serum allergy testing may be considered if an allergic component is suspected, especially in seasonal cases. Results can guide environmental management and potential immunotherapy.

Trigeminal-Mediated Headshaking: The Core Pathophysiology

When all other causes have been ruled out, the diagnosis is most often trigeminal-mediated headshaking. This condition is believed to be a form of neuropathic pain, where the trigeminal nerve becomes hypersensitive and fires inappropriately in response to normal stimuli like light, wind, or touch.

Triggers and Seasonality

A study on equine headshaking syndrome in Australia identified common triggers including sunlight, wind, and exercise, and confirmed a strong seasonal pattern in many cases (Animals, 2024). This seasonality suggests a possible photic or allergic trigger. The infraorbital nerve, a branch of the maxillary division of the trigeminal nerve, is the most commonly implicated site.

The seasonal nature of many cases supports the theory that light intensity or wavelength may play a role in triggering nerve firing. Some horses show signs only during specific times of day or under certain weather conditions.

The Role of the Nose Net

The nose net is a simple and effective diagnostic and therapeutic tool. It works by providing constant, mild sensory input to the trigeminal nerve, which may help to gate or block the abnormal pain signals. A positive response to a nose net is a strong indicator of trigeminal-mediated headshaking.

The nose net should be fitted properly to cover the muzzle area without causing chafing. Owners should trial the net for at least one week during normal exercise to assess response.

Medical Management Options

Medical management is the first line of treatment for trigeminal-mediated headshaking. The goal is to reduce the abnormal nerve firing and improve the horse's quality of life.

Gabapentin

Gabapentin is a structural analogue of GABA that is used to treat neuropathic pain in many species. It is commonly used in horses with headshaking.

Mechanism of Action: Gabapentin binds to the alpha-2-delta subunit of voltage-gated calcium channels, reducing the release of excitatory neurotransmitters. This action dampens abnormal nerve signaling without affecting normal nerve conduction.

Clinical Use: It is often used as a first-line medical therapy. Response is variable, and some horses may require dose titration over several weeks. Start at a low dose and increase gradually based on response and side effects.

Limitations: Gabapentin has poor oral bioavailability in horses, meaning a large portion of the drug is not absorbed. This can make dosing challenging. It can also cause sedation, especially at higher doses. Owners should be warned about potential ataxia or drowsiness, particularly during the first few days of treatment.

Cyproheptadine

Cyproheptadine is an antihistamine with antiserotonergic properties. It has been used historically for headshaking, particularly in seasonal cases.

Mechanism of Action: It blocks histamine H1 receptors and serotonin 5-HT2 receptors. The rationale for its use is based on the theory that headshaking may be triggered by an allergic or photic mechanism involving serotonin.

Clinical Use: It is often tried in horses that do not respond to gabapentin or in seasonal cases. Some practitioners use it in combination with gabapentin.

Limitations: Evidence for its efficacy is limited and largely anecdotal. It can cause sedation and decreased appetite. The response may take several weeks to become apparent.

Other Medical Options

Corticosteroids: A short course of systemic corticosteroids may be tried in acute, severe cases or when an allergic component is suspected. Long-term use is not recommended due to side effects including laminitis risk, immunosuppression, and adrenal suppression.

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): NSAIDs like flunixin meglumine or phenylbutazone are generally not effective for neuropathic pain but may help if there is a concurrent inflammatory component. They are not recommended as sole therapy for trigeminal-mediated headshaking.

Melatonin: Some practitioners have tried melatonin for its potential to modulate photic sensitivity, but evidence is lacking. It may be considered in seasonal cases with suspected light sensitivity.

Routine Veterinary Escalation Criteria

If a horse does not show any improvement after 4 to 6 weeks of appropriate medical therapy, or if side effects are unacceptable, referral to a specialist such as a veterinary neurologist or surgeon is recommended. Consider referral earlier if the horse shows progressive worsening or develops new neurologic signs.

Surgical Management Options

For horses that do not respond to medical management, surgical options may be considered. These procedures are more invasive and carry higher risks.

Percutaneous Electrical Nerve Stimulation (PENS)

PENS is a minimally invasive procedure that involves inserting a needle electrode near the infraorbital nerve and delivering a low-frequency electrical current. A review of electrical nerve stimulation for equine headshaking discussed its potential as a management tool (The Veterinary clinics of North America. Equine practice, 2019).

Procedure: The horse is sedated, and a needle electrode is placed percutaneously at the infraorbital foramen. A series of electrical stimulations are delivered over a short period, typically 15 to 30 minutes. The exact protocol varies between practitioners.

Mechanism of Action: The electrical stimulation is thought to disrupt the abnormal nerve firing and reset the nerve's threshold. This may provide temporary relief by altering the nerve's excitability.

Outcomes: Response is variable. Some horses show significant improvement for weeks to months, while others do not respond. The procedure may need to be repeated at intervals depending on the duration of effect.

Limitations: PENS requires specialized equipment and training. It can be painful and may cause temporary swelling or nerve damage. Not all horses are candidates, and the procedure may not be available in all regions.

Surgical Neurectomy

Surgical neurectomy involves cutting the infraorbital nerve to permanently block sensation to the face.

Procedure: The nerve is surgically exposed and a section is removed under general anesthesia. The approach is made through a small incision over the infraorbital foramen.

Outcomes: This procedure can be effective in eliminating the headshaking behavior. Success rates vary depending on the completeness of nerve transection and the specific nerve branches involved.

Limitations: It is a permanent and irreversible procedure. It results in complete numbness of the upper lip and nostril on the affected side, which can lead to self-trauma such as biting the lip and difficulty eating. It is generally considered a last resort after other options have failed.

Other Surgical Options

Laser Ablation: Laser energy can be used to ablate the nerve. This is less invasive than surgical neurectomy but may have a higher rate of nerve regrowth. The procedure can be performed standing with sedation.

Cryoablation: Freezing the nerve can also provide temporary relief. The nerve is frozen using a cryoprobe, which disrupts nerve conduction. Effects may last weeks to months before nerve regeneration occurs.

Records and Measurements

Accurate record-keeping is essential for monitoring response to treatment and making informed decisions.

Owner Diary

Ask the owner to keep a daily diary documenting:

• Frequency and severity of headshaking episodes, such as number of episodes per ride and severity on a scale of 1 to 10
• Time of day and weather conditions
• Activity level including rest, walking, trotting, and cantering
• Any medications given and their doses
• Any side effects observed
• Response to nose net or other environmental modifications

Video Documentation

Encourage owners to take short video clips of the horse's behavior, both at rest and during exercise. This provides objective evidence of the condition and response to treatment. Videos should be taken under consistent conditions for comparison.

Standardized Assessment Tools

Consider using a standardized scoring system to quantify the condition and track changes over time. A simple scale might include:

• 0: No headshaking observed
• 1: Mild headshaking, does not interfere with riding
• 2: Moderate headshaking, interferes with riding but horse can be managed
• 3: Severe headshaking, horse cannot be ridden safely
• 4: Headshaking present at rest, horse shows signs of distress

Common Failure Patterns

Understanding why treatments fail can help you adjust your approach.

Failure Pattern 1: Incomplete Diagnostic Workup

The most common reason for treatment failure is an incomplete diagnostic workup. If a primary cause like dental disease, sinusitis, or ocular pain is missed, treating for trigeminal-mediated headshaking will be ineffective. Always ensure a thorough ophthalmic, dental, and upper airway examination has been performed before labeling the condition as idiopathic.

Failure Pattern 2: Inadequate Dosing or Duration of Medical Therapy

Gabapentin and cyproheptadine often require dose titration and several weeks of therapy before a response is seen. Owners may stop treatment too early or use sub-therapeutic doses. Clear communication about the expected timeline and the need for dose adjustments is critical. Recheck appointments at 2 to 4 week intervals allow for dose adjustments based on response.

Failure Pattern 3: Unrealistic Owner Expectations

Some owners expect a complete cure. It is important to explain that for many horses, the goal is management, not elimination, of the behavior. A horse that headshakes 80% less but still shows occasional signs may be considered a successful outcome. Set realistic goals at the outset of treatment.

Failure Pattern 4: Concurrent Pain or Stress

Horses with headshaking may also have other sources of pain, such as lameness or back pain, which can exacerbate the behavior. Addressing all sources of pain and stress is important. An early survey on equine headshaking noted that the condition can be associated with other behavioral issues (The Veterinary record, 1997). Evaluate the horse for concurrent musculoskeletal problems that may contribute to the overall clinical picture.

Failure Pattern 5: Environmental Triggers Not Addressed

Even with appropriate medical therapy, horses may continue to show signs if environmental triggers are not managed. Sunlight, wind, dust, and pollen can all trigger episodes. Recommend environmental modifications such as turnout during low-light hours, use of fly masks with nose covers, and stabling during windy conditions.

Welfare and Safety Context

Equine headshaking syndrome has significant welfare implications. The constant, uncontrollable head movements can cause physical injury to the horse, such as hitting its head on a stall wall, and make it dangerous to handle or ride. The condition can also cause significant stress and frustration for the horse.

Rider Safety

A horse that headshakes violently can be dangerous to ride. The sudden, jerky movements can unseat the rider or cause the horse to bolt. It is important to advise owners to ride with caution and consider using a safe, well-fitted bridle and a nose net. Riders should wear appropriate safety gear including a helmet and body protector.

Horse Welfare

The underlying neuropathic pain is likely distressing for the horse. Treatment should aim to improve the horse's quality of life. If medical and surgical options are exhausted and the horse's welfare is severely compromised, euthanasia may be the most humane option. The World Organisation for Animal Health (WOAH) provides guidelines on animal welfare that should be considered in all management decisions (Animal Health and Welfare, WOAH).

Long-Term Management Considerations

Horses with headshaking may require lifelong management. Regular re-evaluation is important to assess response to treatment and adjust the plan as needed. Some horses may experience spontaneous improvement over time, while others may worsen. Owners should be prepared for the possibility of ongoing treatment and monitoring.

Practical Decision Framework for Selecting and Adjusting Therapy in Equine Headshaking Syndrome

Selecting the appropriate therapy for a horse with trigeminal-mediated headshaking requires a structured approach that accounts for individual variation in response, seasonal patterns, and owner capacity for treatment administration. A stepwise decision framework helps avoid the common failure pattern of abandoning treatment prematurely or switching therapies without adequate trial duration. This framework is designed for use after a complete diagnostic workup has ruled out other causes of headshaking, as described in the diagnostic section above.

Tiered Treatment Selection Algorithm

The following algorithm organizes treatment options into tiers based on invasiveness, cost, and evidence base. Each tier should be trialed for a minimum of four to six weeks before moving to the next tier, unless unacceptable side effects or worsening of signs occur.

Tier 1: Environmental Modification and Mechanical Devices

Begin with the least invasive interventions that carry no pharmacologic side effects. These measures should be implemented for at least two weeks before adding medical therapy.

• Nose net trial: Fit a properly designed equine nose net that covers the muzzle area from the nostrils to the level of the facial crest. The net should be snug but not tight, allowing the horse to open its mouth normally. Instruct the owner to use the net during all exercise and turnout for a minimum of 14 consecutive days. Document the horse's response using the standardized scoring system described in the records section. A positive response, defined as a reduction of at least two points on the 0 to 4 severity scale, supports the diagnosis of trigeminal-mediated headshaking and may be sufficient as sole management for mild cases.
• Light management: For horses with a clear seasonal pattern or worsening in bright sunlight, recommend turnout during early morning or evening hours when UV index is lower. Use a full-face fly mask with a nose extension that blocks light from reaching the muzzle area. Some owners report benefit from stabling the horse during peak sunlight hours, typically 10 AM to 4 PM in summer months.
• Wind and dust protection: In windy conditions, stable the horse or use a lightweight sheet that covers the head and neck. Avoid turnout in dusty paddocks or near hay feeding areas during peak pollen seasons. Consider using a misting system or dampening the stable floor to reduce airborne particulates.

Tier 2: First-Line Medical Therapy

If environmental modifications alone are insufficient after two weeks, initiate medical therapy. The choice between gabapentin and cyproheptadine depends on the clinical presentation and owner preference.

• Gabapentin as first choice: Start gabapentin in horses with moderate to severe headshaking that interferes with riding or quality of life. Begin at a dose of 5 to 10 mg/kg orally every 8 to 12 hours. Titrate upward every 5 to 7 days based on response and side effects, up to a maximum of 20 mg/kg per dose. Monitor for sedation, ataxia, or decreased appetite during the first week. If sedation occurs, reduce the dose and extend the titration period. Maintain the effective dose for at least four weeks before assessing full response.
• Cyproheptadine for seasonal cases: Consider cyproheptadine as first-line therapy in horses with a strong seasonal pattern, particularly those that worsen in spring and summer. Start at 0.3 mg/kg orally every 12 hours. Increase gradually to 0.5 mg/kg every 12 hours if no response after two weeks. Monitor for sedation and decreased appetite. The full effect may take three to four weeks to become apparent.
• Combination therapy: If monotherapy with either drug produces a partial response after four weeks, consider adding the second drug. For example, a horse that shows 50% improvement on gabapentin may benefit from adding cyproheptadine at the starting dose. Monitor for additive sedation when combining these medications.

Tier 3: Second-Line Medical Therapy and Adjunctive Treatments

If Tier 2 therapies fail to produce an acceptable response after six to eight weeks, consider the following options. These should be prescribed by a veterinarian experienced in equine headshaking management.

• Melatonin trial: For horses with photic sensitivity, particularly those that worsen in bright light or show signs only during specific times of day, a trial of melatonin may be considered. Administer 10 to 30 mg orally once daily in the late afternoon. The rationale is to modulate circadian rhythms and potentially reduce light-triggered nerve firing. Evidence is limited to anecdotal reports, and response is unpredictable. Trial for four weeks before assessing efficacy.
• Corticosteroid pulse: In horses with acute worsening or suspected allergic component, a short course of systemic corticosteroids may provide temporary relief. Use prednisolone at 1 mg/kg orally once daily for five to seven days, then taper over one week. Do not repeat courses more than twice per year due to risks of laminitis, immunosuppression, and adrenal suppression. Document any response carefully, as a positive response may suggest an inflammatory component that warrants further allergy investigation.
• Magnesium supplementation: Some practitioners recommend magnesium as a adjunctive therapy for neuropathic pain. Provide magnesium oxide or magnesium sulfate at 10 to 20 mg/kg orally once daily. Evidence for efficacy in equine headshaking is lacking, but the supplement is generally safe and inexpensive. Trial for four weeks alongside other therapies.

Tier 4: Interventional Procedures

If medical management fails or produces unacceptable side effects, discuss interventional options with the owner. These procedures require referral to a specialist facility.

• Percutaneous electrical nerve stimulation (PENS): This is the least invasive interventional option. The procedure involves placing a needle electrode near the infraorbital nerve under sedation and delivering low-frequency electrical stimulation for 15 to 30 minutes. A review of electrical nerve stimulation for equine headshaking discussed its potential as a management tool (The Veterinary clinics of North America. Equine practice, 2019). The horse may require repeat treatments every four to eight weeks depending on the duration of effect. Success rates vary widely, and not all horses respond. Discuss the possibility of temporary swelling, nerve irritation, or lack of response with the owner before proceeding.
• Cryoablation or laser ablation: These techniques disrupt nerve conduction by freezing or burning the nerve tissue. They can be performed standing with sedation. The effects are temporary, lasting weeks to months, as the nerve regenerates. Repeat procedures may be needed. These options are less commonly available than PENS and carry risks of incomplete nerve ablation or collateral tissue damage.
• Surgical neurectomy: This is a permanent and irreversible procedure reserved for horses that have failed all other options and have severely compromised welfare. The infraorbital nerve is surgically exposed and a section is removed under general anesthesia. Success rates depend on complete nerve transection, but the procedure results in permanent numbness of the upper lip and nostril on the affected side. Owners must be counseled about the risk of self-trauma, difficulty eating, and the potential for the horse to bite its own lip. This is considered a last resort.

Decision Points for Escalation or Change

Use the following criteria to determine when to escalate therapy or switch to a different treatment modality.

Criteria for Escalating from Tier 1 to Tier 2:

• No improvement after 14 days of consistent environmental modification and nose net use
• Partial improvement that is insufficient for safe riding or handling
• Owner reports that the horse shows signs of distress despite environmental changes

Criteria for Escalating from Tier 2 to Tier 3:

• Less than 50% reduction in headshaking severity after six weeks of optimal medical therapy
• Unacceptable side effects such as persistent sedation, ataxia, or decreased appetite that do not resolve with dose adjustment
• Progressive worsening of signs despite medication

Criteria for Escalating from Tier 3 to Tier 4:

• Failure of two different medical therapy regimens after adequate trial durations
• Horse shows severe headshaking that prevents eating, drinking, or safe handling
• Owner is unable to continue medical therapy due to cost, logistics, or side effects
• Horse's welfare is significantly compromised, and less invasive options have been exhausted

Monitoring and Adjustment Protocol

Establish a structured monitoring schedule to track response and guide adjustments.

Week 1 to 2: Initiate therapy at the starting dose. Instruct the owner to record headshaking severity daily using the 0 to 4 scale. Note any side effects. Schedule a telephone check-in at day 7 to assess tolerance and make initial dose adjustments if needed.

Week 3 to 4: Continue therapy at the adjusted dose. Ask the owner to take video recordings of the horse at rest and during exercise under consistent conditions. Compare these to baseline videos taken before treatment began. Schedule a recheck examination at week 4 to assess response and review the owner diary.

Week 6 to 8: If response is inadequate, consider dose escalation or adding a second medication. If the horse shows a good response, defined as a reduction of at least two points on the severity scale, continue the current regimen and schedule a follow-up in three months.

Long-term monitoring: Once a stable regimen is established, schedule rechecks every three to six months. Seasonal changes may require dose adjustments or temporary addition of medications. Some horses may experience spontaneous improvement over time, allowing dose reduction or discontinuation of therapy under veterinary guidance.

Common Failure Patterns in Therapy Selection

Understanding why specific therapies fail can help refine the treatment plan.

Failure Pattern 1: Inadequate Dose or Duration

The most common reason for medical therapy failure is stopping treatment too early or using sub-therapeutic doses. Gabapentin has poor oral bioavailability in horses, meaning a large portion of the drug is not absorbed. Doses that appear adequate on paper may produce low blood levels. If a horse shows no response after four weeks at the maximum tolerated dose, consider measuring serum gabapentin levels if available, or switch to an alternative therapy. Cyproheptadine may require three to four weeks to reach full effect, and owners may abandon treatment prematurely.

Failure Pattern 2: Incorrect Drug Selection for the Clinical Phenotype

Not all headshaking cases respond to the same medications. Horses with a strong seasonal pattern and photic sensitivity may respond better to cyproheptadine or melatonin than to gabapentin. Horses with year-round signs and no clear triggers may respond better to gabapentin. If the initial drug choice fails, switch to the alternative instead of adding a second drug immediately. This allows clear assessment of each drug's efficacy.

Failure Pattern 3: Unaddressed Environmental Triggers

Even with optimal medical therapy, horses may continue to show signs if environmental triggers are not managed. Sunlight, wind, dust, and pollen can all trigger episodes. Review the owner diary for patterns related to weather, time of day, and location. Adjust environmental management accordingly. A horse that improves on medication but still headshakes during turnout in bright sunlight may benefit from a full-face fly mask or altered turnout schedule.

Failure Pattern 4: Concurrent Pain or Stress

Horses with headshaking may have other sources of pain that exacerbate the behavior. Lameness, back pain, or dental discomfort can lower the threshold for trigeminal nerve firing. Evaluate the horse for concurrent musculoskeletal problems and address them alongside headshaking therapy. An early survey on equine headshaking noted that the condition can be associated with other behavioral issues (The Veterinary record, 1997). A horse that is stressed by stable confinement, social isolation, or training demands may show worsening of signs despite appropriate medical therapy.

Failure Pattern 5: Owner Non-Compliance or Misunderstanding

Complex dosing schedules, side effects, and the need for prolonged treatment can lead to owner non-compliance. Clearly explain the expected timeline, potential side effects, and the importance of consistent medication administration. Provide written instructions for dose titration and monitoring. Schedule regular check-ins to maintain engagement and address concerns. If the owner is unable to administer medications reliably, consider simpler regimens or interventional options.

Records and Measurements for Therapy Adjustment

Accurate record-keeping is essential for making informed decisions about therapy changes.

Owner Diary Template

Provide the owner with a structured diary to complete daily. Include the following fields:

• Date and time of day
• Weather conditions: sunny, cloudy, windy, rainy
• Activity: rest, walking, trotting, cantering, turnout
• Headshaking severity score (0 to 4)
• Number of headshaking episodes observed during a 10-minute period at rest and during exercise
• Medications administered: drug, dose, time
• Any side effects observed
• Nose net used: yes or no
• Other environmental modifications in place

Video Documentation Protocol

Ask the owner to record a two-minute video of the horse at rest in the stable or paddock and a two-minute video during exercise at the walk and trot. Record under consistent conditions each time, such as the same time of day and same location. Label each video with the date and treatment phase. Compare videos side by side to assess changes objectively.

Standardized Assessment at Recheck Examinations

At each recheck, perform the following assessments:

• Observe the horse at rest in a quiet environment for five minutes. Record the severity score.
• Observe the horse during lunging or riding at walk, trot, and canter for five minutes each. Record the severity score for each gait.
• Palpate the infraorbital nerve region for signs of pain or sensitivity.
• Review the owner diary and video recordings.
• Assess for side effects of medication: sedation, ataxia, appetite, demeanor.
• Adjust the treatment plan based on the findings.

Professional Escalation Criteria

If the horse does not show an acceptable response after trialing two different medical therapy regimens for adequate durations, or if the horse develops new neurologic signs, refer to a veterinary neurologist or a specialist in equine headshaking. Consider referral earlier if the horse shows any of the following:

• Progressive worsening of headshaking despite optimal therapy
• Development of ataxia, weakness, or other neurologic deficits
• Signs of severe pain such as reluctance to eat, weight loss, or self-trauma
• Owner requests consideration of interventional procedures
• The horse's welfare is severely compromised, and all reasonable medical options have been exhausted

A study on idiopathic headshaking questioned whether the condition is truly idiopathic, suggesting that some cases may have an underlying infectious or inflammatory component (Veterinary journal, 2014). Referral for advanced imaging such as MRI of the brain and trigeminal nerve may be indicated in refractory cases to rule out intracranial pathology that was not apparent on initial diagnostics.

Frequently Asked Questions

What is the difference between idiopathic headshaking and trigeminal-mediated headshaking?

Idiopathic headshaking is a diagnosis of exclusion, meaning no specific cause is found after a thorough diagnostic workup. Trigeminal-mediated headshaking is a specific form of idiopathic headshaking where the trigeminal nerve is believed to be the source of the abnormal sensation. In practice, the terms are often used interchangeably, but trigeminal-mediated headshaking implies a more specific pathophysiology supported by clinical signs such as response to nose net and seasonal pattern.

Can a horse with headshaking be ridden safely?

Many horses with headshaking can be ridden, especially if the condition is mild to moderate and well-managed. A nose net is often very helpful. However, if the headshaking is severe or dangerous, riding should be avoided until the condition is better controlled. Riders should always wear appropriate safety gear and be prepared for sudden movements.

Is headshaking more common in certain breeds or ages?

Some studies suggest that headshaking may be more common in Thoroughbreds and Warmbloods, but it can affect any breed. A study on the prevalence of headshaking within the equine population in the UK did not find a strong breed predisposition (Equine veterinary journal, 2018). The condition can occur at any age but is most commonly reported in middle-aged horses.

How long does it take for gabapentin to work in horses with headshaking?

Response to gabapentin is variable. Some horses show improvement within a few days, while others may require several weeks of therapy at an appropriate dose. It is important to titrate the dose gradually and give the medication time to work. Owners should be advised to continue treatment for at least 4 weeks before assessing response.

What is the success rate of percutaneous electrical nerve stimulation for headshaking?

The success rate of PENS is variable and depends on the individual horse and the technique used. Some studies report a good to excellent response in a significant percentage of horses, but not all horses respond. It is not a guaranteed cure, and the procedure may need to be repeated. A review of electrical nerve stimulation for equine headshaking discussed its potential as a management tool (The Veterinary clinics of North America. Equine practice, 2019).

Can headshaking be caused by allergies?

Yes, an allergic component is suspected in many cases, particularly those with a seasonal pattern. Allergens such as pollen, dust, or mold may trigger the trigeminal nerve. Allergy testing and environmental management may be helpful in these cases. A study on equine headshaking syndrome in Australia identified common triggers including sunlight, wind, and exercise, and confirmed a strong seasonal pattern in many cases (Animals, 2024).

Is there a link between headshaking and equine herpesvirus?

A study found latent equine herpesvirus-1 in the trigeminal ganglia of some horses with idiopathic headshaking, suggesting a possible link (Journal of veterinary internal medicine, 2012). However, this does not prove causation, and many horses with EHV do not develop headshaking. The role of viral reactivation in triggering headshaking episodes remains an area of ongoing research.

What should I do if my horse suddenly starts headshaking violently?

If the headshaking is acute and severe, or if the horse shows any other signs of illness or neurologic disease, contact your veterinarian immediately. This could be a sign of a more serious condition such as a fracture, infection, or neurologic problem. Do not attempt to ride the horse until a veterinary examination has been performed.

Related Veterinary Guides

• California Medical
• Medical Certificate
• Diagnostic Medical Sonography Programs
• Clinical Biochemistry Urinalysis
• Veterinary Clinical Methods Procedures Surgical Interventions

References and Further Reading

• aaep.org
• www.merckvetmanual.com
• www.acvim.org
• Merck Veterinary Manual. Merck Veterinary Manual.
• Animal Health and Welfare. World Organisation for Animal Health.
• Equine Headshaking Syndrome: Triggers, Seasonality, and Treatment Efficacy in Australia.. Animals : an open access journal from MDPI, 2024.
• Prevalence of headshaking within the equine population in the UK.. Equine veterinary journal, 2018.
• Is Electrical Nerve Stimulation the Answer for Management of Equine Headshaking?. The Veterinary clinics of North America. Equine practice, 2019.
• Equine headshaking survey.. The Veterinary record, 1997.
• Latent equine herpesvirus-1 in trigeminal ganglia and equine idiopathic headshaking.. Journal of veterinary internal medicine, 2012.
• Idiopathic headshaking: is it still idiopathic?. Veterinary journal (London, England : 1997), 2014.
• Trigeminal nerve root demyelination not seen in six horses diagnosed with trigeminal-mediated headshaking. Frontiers in Veterinary Science, 2017.

This article is educational and is not a substitute for veterinary diagnosis or treatment. Contact a veterinarian for advice about an individual animal.